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Skin absorption testing in vitro is a regulatory accepted alternative method (OECD Guideline 428).
Different tests can be applied to evaluate the integrity of the skin samples. Here, we compared the pre-
or post-run integrity tests (transepidermal electrical resistance, TEER; transepidermal water loss, TEWL;
absorption of the reference compounds water, TWF, or methylene blue, BLUE) and additionally focused
on co-absorption of a 3H-labeled internal reference standard (ISTD) as integrity parameter. The results
were correlated to absorption proﬁles of various test compounds. Limit values of 2 kX, 10 g m2 h1
and 4.5 ⁄ 103 cm h1 for the standard methods TEER, TEWL and TWF, respectively, allowed distinguish-
ing between impaired and intact human skin samples in general. Single skin samples did, however, not,
poorly and even inversely correlate with the test-compound absorption. In contrast, results with ISTD
(e.g. 3H-testosterone) were highly correlated to the absorption of 14C-labeled test compounds. Impor-
tantly, ISTD did not inﬂuence analytics or absorption of test compounds. Therefore, ISTD, especially when
adjusted to the physico-chemical properties of test compounds, is a promising concept to assess the integ-
rity of skin samples during the whole course of absorption experiments. However, a historical control
dataset is yet necessary for a potential routine application.
 2014 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
For compounds which may get in contact with the skin, knowl-
edge of dermal absorption is necessary to estimate the systemic
exposure and perform risk assessments. For the determination of
the systemic available amount of a compound in contact with the
skin in vivo, in vitro and in silico methods are established (Schäfer
and Redelmeier, 1996b). The in vitro method outlined in the OECDtest guideline no. 428 is accepted by many regulatory agencies and
is in accordance with the aim to reduce animal testing (OECD,
2004a, 2004b). Excised human or animal skin is mounted on a dif-
fusion chamber, test compound is applied topically and the pene-
trated and permeated amount is measured in the skin sample and
the underlying receptor ﬂuid. The protocol was subject of multicen-
ter validation studies as laid down (van de Sandt et al., 2004) and
following speciﬁcations of e.g. skin type and handling (Schäfer-
Korting et al., 2006, 2008). To avoid unsuitable over-prediction of
the dermal absorption by the use of impaired skin preparations,
the OECD guideline requires a skin integrity check. This test should
ensure the exclusive use of data generated with skin with intact
barrier function. In addition to a visual examination of the skin,
the guideline proposes measuring the TEER (transepidermal
electrical resistance), TEWL (transepidermal water loss) or the
absorption characteristics of a reference compound in advance or
at the end of an experiment, e.g. 3H-water (TWF, transepidermal
water ﬂux), or concurrently by adding an internal reference stan-
dard (ISTD) with high speciﬁc activity to the test compound prepa-
ration, e.g. 3H-sucrose (OECD, 2004a, 2004b).
Widely used standard methods in many laboratories are TWF
and TEWL and TEER (Diembeck et al., 1999; Meidan and Roper,
2008). Despite intensive investigations, there is an ongoing debate
about experimental performances, limit values and ﬁelds of
114 K. Guth et al. / Toxicology in Vitro 29 (2015) 113–123application (Brain et al., 1995; Chilcott et al., 2002; Meidan and
Roper, 2008; Netzlaff et al., 2006). For example, TWF is a widely
used and established marker for skin barrier function with a large
historical dataset (Bronaugh et al., 1986; Meidan and Roper, 2008).
Yet, the application of an inﬁnite dose of water and therefore
hydration for several hours, followed by the necessary removal
and wash, may cause physical deterioration of the skin and higher
permeability afterwards (Brain et al., 1995) whereas TWF mea-
surement at the end of the experiment may lead to rejection of
previously intact skin samples. Because of most similar treatment
of the skin this is conceivable for TEER (Davies et al., 2004;
Fasano et al., 2002), too. Also, TEWL is widely used as a marker
for skin barrier function in vitro and in vivo. While avoiding phys-
ical stress to the skin (Levin and Maibach, 2005), like TEER and
TWF, TEWL provides only a snapshot before or after an experiment.
However, vehicle ingredients can damage the stratum corneum
structure and hydration level; deterioration with time has been
reported (Buist et al., 2005; Shah et al., 2008). The same holds true
for the integrity test BLUE which utilizes the absorption of methy-
lene blue as a measure for barrier functionality.
In contrast to TWF, TEER, TEWL and BLUE the integrity test ISTD
supplies information of the barrier function over the whole exper-
imental period and avoids the elongation of the test period. But the
presence of an additional compound in the donor may inﬂuence
the absorption characteristic of the test compound because of
changes in solubility or saturation levels of the test compound
and effects of the solvent on the barrier system (Barry, 1987;
Dugard and Scott, 1986). Due to this inﬂuence the inertness of an
ISTD must be proven. 3H-sucrose and phenol red have been used
as ISTD in the past, but systematic validation and provision of a
sufﬁcient dataset is still missing (Balaguer et al., 2006;
Pendlington et al., 1997; Walters et al., 1997).
The purpose of the current work was to investigate the suitabil-
ity of different skin integrity tests to differentiate impaired and
intact human skin. Based on the absorption results of four test com-
pounds (testosterone, caffeine, 2-ethyl-4-chlorophenoxyacetic acid
(MCPA) and 2-methyl-4-chlorophenoxyacetyl ethylhexylester
(MCPA-EHE)) through human and generally more permeable
reconstructed human skin (StrataTest), the common limit values
for the standard integrity methods TEER, TWF and TEWL were
assessed. Additionally, results of ﬁve skin integrity tests (TEER,
TWF, TEWL, ISTD and BLUE) were correlated to absorption results
derived with human skin or reconstructed human skin to evaluate
their ability to explain minor differences in barrier function.
Full-thickness and dermatomed human skin samples were applied
to check for a possible effect of the skin preparation. Due to a lower
donor dependency, rat skin was used in addition and chosen for a
special experiment in which skin samples were systematically
damaged to different grades before use. As model ISTD 3H-testos-
terone was chosen. It was applied in parallel to test compound
14C-MCPA. For human skin experiments two further well-
investigated reference compounds with different physico-chemical
properties were applied as ISTDs (3H-caffeine and 3H-mannitol)
(OECD, 2004a; Peck et al., 1995; Schäfer-Korting et al., 2008; van
de Sandt et al., 2004) to get an insight on the effect of ISTD selection.
Additional experiments were conducted to check for effects of the
present ISTDs on the analytics and absorption characteristics of
the test compound.
2. Materials and methods
2.1. Chemicals and reagents
MCPA-2EHE, MCPA, dimethylamine (DMA; 60%), silicone anti-
foam emulsion (SRE) and ethylenediaminetetraacetic acid (EDTA)
were provided by AH Marks and Co, Wyke, Bradford, Great Britain.Testosterone, caffeine, ethanol andmethylene blue were purchased
from Sigma Aldrich, St. Louis, MO, USA, bovine serum albumin
(BSA) was from Roche, Basel, Switzerland, Texapon N70 from Cog-
nis, Düsseldorf, Germany, NaCl from Merck, Darmstadt, Germany
and Soluene 350 and scintillation cocktail Hionic Fluor™ from
Perkin–Elmer, Boston, MA, USA. Radiolabeled compounds (radio-
chemical purity >97%) were supplied by American Radiolabeled
Chemicals, St. Louis, MO, USA (3H-caffeine with 2.22 TBq mmol1),
Perkin–Elmer (14C- and 3H-testosterone with 2.1 GBq mmol1 and
6.3 TBq mmol1, respectively, 14C-caffeine with 1.89 GBq mmol1
and 3H-mannitol with 455.6 GBq mmol1, 3H-Water with
37 MBq ml1) or by AH Marks and Co (14C-MCPA with
1.88 GBq mmol1 and 14C-MCPA-2EHE with 1.02 GBq mmol1).
The radioactive isotopes are generally located at stable positions
of themolecule: 14C in the A ring of the steroid testosterone, in phe-
nyl ring of MCPA and MCPA-EHE and in the methyl group at N-1 of
caffeine; 3H generally at non-acidic groups (testosterone at posi-
tions C-1, C-2, C-6, C-7, C-16 and C-17, mannitol at C-1 and caffeine
in methyl group at N-1).
2.2. Skin preparations
Split-thickness (450 ± 100 lm) and full-thickness (1000 ±
200 lm) female human skin samples from abdominal surgery were
purchased from Biopredic, France. Rat skin was excised from the
back of eight-week-old female Crl:WI (Han) rats (Charles River,
Germany) after sedation with isoﬂurane and exsanguination.
Split-thickness skin (450 ± 100 lm) was generated with a Derma-
tome GA 643 (Aesculap, Germany) after hair trimming. For a spe-
cial investigation various grades of barrier impairment were
induced by stressing excised rat skin with chemical or mechanical
treatment in advance of experiments using 14C-MCPA as the test
substance. Such pretreatment scenarios comprises combinations
of water application or application of MCPA formulation (see
Table 1) with or without MCPA and one or three washing steps
with cotton swabs and 0.7% aqueous Texapon N70 solution over
three consecutive days. The individual treatments are given in
Table 2. Experiments 1–3 comprise the ‘undamaged’ skin and
experiments 4–9 the ‘damaged’ skin. StrataTest (100–115 lm)
purchased from Stratatech Corporation, USA, is a reconstructed
human skin model which was added in the current setup as a
human skin system with generally lower barrier functionality.
2.3. In vitro dermal absorption study
All studies were conducted following the OECD-Guideline 428
and the corresponding technical guidance document 28 (OECD,
2004a, 2004b). Five skin samples per run, derived from at least
two different donors, were mounted on Franz type diffusion cells
with a surface area of 1 cm2 and receptor volume of 4 ml (Labora-
tory Glass Apparatus Inc., USA). The water jacket around the recep-
tor compartment was maintained using a water thermostat pump
(Thermo Haake, Germany) at a temperature of 32 C. A ﬁnite dose
was applied to the surface of the skin under occlusive (Paraﬁlm
‘‘M’’, Pechiney Plastic Packaging, USA) or semi-occlusive (Fixo-
mull, BSN medical, Germany) conditions. The receptor ﬂuid was
chosen to provide an adequate solubility of the test compound –
at least 10 times higher than the maximal achievable concentration
(see Tables 1 and 3). After exposure for 6 or 24 h the compoundwas
washed off with cotton swabs and washing ﬂuid. During the exper-
imental period, samples were taken from the stirred (magnetic stir-
rers, Variomag Telemodul 20C/40C, H + P Labortechnik, Germany)
receptor ﬂuid at distinct time points and replaced with fresh recep-
tor ﬂuid by a fraction collector (222 L, Abimed, Germany) and a
multi-channel peristaltic pump (MC 360, Ismatec, Germany). At
the end of the run each diffusion cell was dismantled and all parts
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K. Guth et al. / Toxicology in Vitro 29 (2015) 113–123 115were processed for balancing. Two to six tape strips (Crystal Clear
Tape 600, Scotch, France) were used to remove the upper stratum
corneum from the skin samples. The tapes with stratum corneum
and the remaining skin were digested with Soluene 350, lasting
a minimum of 24 h; cotton swabs as well as the class devices were
extractedwith ethanol or water – depending on the solubility of the
test compounds. All samples were diluted with LSC-Cocktail and
measured by Liquid Scintillation Counting (LSC; TriCab 2800TR,
Perkin-Elmer, USA; linear range up to 1,000,000 dpm). Absolute
and percentage amounts in receptor ﬂuid, skin, tape strips and
washing ﬂuids were calculated as well as the total recovery. Only
a recovery of 100 ± 10% was assumed to be valid for mean calcula-
tions. The sum of content in receptor ﬂuid (including receptor
chamber washings) and skin was deﬁned as the potentially absorb-
able dose (AD); if applicable also the amount recovered from the
underlying membrane of the reconstructed human skin was
assigned to AD. The cumulative absorbed amount was plotted
against time. The steepest slope – the maximal absorption rate in
lg cm2 h1 – divided by the applied concentration in lg cm3 pro-
vides the maximal permeability constant maxKp in cm h1. The
intercept of the elongated steepest slope line with the x-axis repre-
sents the lag time (h). Test compound dependent experimental con-
ditions as well as logP andmolecular weight are listed in Table 1. All
four test compounds were applied to full-thickness and split-thick-
ness human skin, 14C-testosterone, 14C-caffeine and 14C-MCPAwere
also applied to rat skin and to reconstructed human skin. Uninten-
tionally damaged skin samples were left in the set up and examined
along with the intact samples. Intentionally impaired rat skin sam-
ples were used for 14C-MCPA experiments.2.4. Integrity tests
Besides a visual check at least two of the ﬁve following integrity
tests were conducted in each experiment, the skin being mounted
on the Franz cell. TEER, TEWL and TWF were performed in advance,
ISTD concurrently and BLUE at the end of the run.2.4.1. TEER
To measure the transepidermal electrical resistance to an alter-
nating current (impedance), the receptor and donor compartment
of the diffusion cell were ﬁlled with physiological saline (0.9%
aqueous NaCl solution). Electrodes were immersed in each com-
partment and the impedance was measured via a LCR bridge
(LCR400, Thurbly Thandar Instruments, Great Britain) at a fre-
quency of 1 kHz. The standard limit value was 1 kX. This value is
based on internal experience and experiments to distinguish native
and punched human skin samples. A lab-speciﬁc limit value is nec-
essary due to limited transferability: The measured resistance is
dependent on the device, applied frequency, resulting current,
ionic strength of the solution as well as the surface area of the skin
sample (Fasano et al., 2002).2.4.2. TEWL
The transepidermal water loss was measured after minimal 1 h
of equilibration and drying of the skin surface. The moisture on the
skin surface originating from rehydration of the frozen skin sam-
ples or from TEER measurement needs to be evaporated to mea-
sure exclusively the water loss through the skin sample. With a
VapoMeter (Delﬁn Technologies Ltd., Finland) the TEWL was deter-
mined under closed chamber conditions (Imhof et al., 2009). For
this end the donor compartment of the diffusion cell was covered
completely with the VapoMeter. The standard limit of 10 g m2 h1
was used (Schäfer and Redelmeier, 1996b).
Table 2
Pretreatment scenarios to obtain various grades of barrier impairment.
Experiment no.a Total experimental time (h) 3 Applications on 3 consecutive days Washing procedure (mechanical stress)
1 24 None None
2 96 None None
3 96 Water None
4 96 Water 8 h after the last application
5 96 Water 8 h after each application
6 96 Blank formulationb None
7 96 Blank formulationb 8 h after each application
8 96 Cold formulationc 8 h after the last application
9 96 Cold formulationc 8 h after each application
a For each experiment 5 replicates were used.
b Blank formulation refers to MCPA application solution without MCPA.
c Cold formulation refers to MCPA application solution with only unlabeled MCPA.
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To determine the absorption characteristics of tritiated,
3H-labeled, water, the receptor compartment was ﬁlled with phys-
iological saline. An inﬁnite dose (300 ll cm2) with a speciﬁc
radioactivity of 123 kBq ml1 was applied to the surface of the
skin. At distinct time points (0.5, 1, 2, 3, 4 and 5 h) receptor ﬂuid
was collected using a syringe. After the last sampling the skin
was thoroughly washed with distilled water and cotton swabs.
Receptor ﬂuid was diluted with scintillation cocktail, measured
by LSC and data were used to calculate the permeability constant
(Kp) as described in Section 2.3. A generally accepted limit value
of 2.5 ⁄ 103 cm h1 was used (Bronaugh et al., 1986). Using TWF
as a pre-test, the radioactivity needs to be removed from the sys-
tem before application of the test compound. Therefore, the recep-
tor ﬂuid was changed several times until the activity in a receptor
ﬂuid aliquot declined to 50 dpm (0.8 Bq).
2.4.4. ISTD
A 3H-labeled internal reference standard was added to the
14C-labeled test compound formulation and applied to the skin
(see Tables 1 and 3). The concentration was determined by the spe-
ciﬁc radioactivity of the 3H-ISTD which was chosen to be equal to
the speciﬁc radioactivity of the 14C-labelled test compound
(Table 1). In all samples 3H-activity was measured along with the
14C-activity by LSC. Absorption characteristics (AD and maxKp)
were determined analogously, as described in Section 2.3.
2.4.5. BLUE
Following the ﬁnal washing procedure at the end of the absorp-
tion experiment, 250 ll of methylene blue, 0.025% aqueous solu-
tion, was applied on top of the skin for 0.5 h and washed off with
0.7% aqueous Texapon N70 solution. The receptor ﬂuid was tested
for permeated dye using a photometer operating at 661 nm. The
concentration in the receptor ﬂuid was determined via a calibra-
tion curve. Any staining of the epidermis was reported before
digestion and processing for LSC measurements.Table 3
Physico-chemical properties of internal standards.
ISTD LogP MW (g mol1) Solubility in water (g l1)
3H-Mannitol 3.1a 182.17 182.2 (20 C)d
3H-testosterone 3.32b 288.4 0.02 (25 C)b
3H-caffeine 0.07c 194.2 20 (20 C)c
logP: logarithmic octanol/water partition coefﬁcient; MW: molecular weight.
a Leo et al. (1971).
b Yalkowsky et al. (1983).
c Merck (2006).
d Sigma-Aldrich (2007).2.5. Assessment of integrity tests
Two methods were used to assess the suitability of the differ-
ent skin integrity tests. Firstly, the ability for binary differentia-
tion of human skin samples was evaluated for the three
standard tests TEER, TEWL and TWF. Therefore, we differentiated
valid and invalid excised or reconstructed human skin samples
according to the standard limit values for human skin set 1 kX,
10 g m2 h1 and 2.5 ⁄ 103 cm h1 and for TEER, TEWL and
TWF, respectively. In addition one further limit value was used
for each test. Based on the outcome, these were more liberal
for TEWL (13 g m2 h1) and TWF (4.5 ⁄ 103 cm h1), yet more
strict for TEER (2 kX). The minimum (min), maximum (max)
and mean absorption results (maxKp and AD) were calculated
separately for the deﬁned valid and invalid groups. Furthermore
we plotted the single cell results for the deﬁned valid and invalid
skin samples.
Next, the ability of all ﬁve integrity tests (TEER, TEWL, TWF,
ISTD and BLUE) to detect and explain minor differences in barrier
function was investigated by correlation analyses. For this task,
rat skin was included, basically, to make use of the in theory lower
donor variability of rat skin for the special investigation in which
rat skin was systematically damaged to various grades. For the cor-
relation analyses we grouped all experiments using the same test
compound (caffeine, testosterone, MCPA or MCPA-EHE) and barrier
system (human, rat or reconstructed human skin) together. Groups
with at least 10 single data points were used for linear regression
analysis of integrity test results (independent variable x) against
absorption results (AD and maxKp, dependent variable y). All data
points were included independent of valid or invalid classiﬁcation.
Slopes and correlation coefﬁcients (R2) were reported for evalua-
tion. Min, max and mean values were calculated for each integrity
test, but only R2 from correlations with the correct algebraic sign
were used.
To assess the variability of the methods and the effect of the
human donor, overall, inter- and intra-donor variabilities were cal-
culated for the different methods. Overall variability is given as the
variation coefﬁcient (CV, often referred to as the relative standard
deviation (SD)) of all skin samples used, inter-donor variability is
given as CV calculated with the mean values for each donor and
intra-donor variability which corresponds to the method variabil-
ity is given as the pooled, average, CV for each donor weighted
by the number of replicates. If from one human donor both, full-
thickness and dermatomed skin, was used, the underlying means
and variabilities were calculated separately. For ISTD and the gen-
eral in vitro dermal absorption method, only the pooled CV could
be calculated due to the various kinds of ISTDs and test compounds
used. Underlying means were calculated separately for each ISTD
or test compound.
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Since energy spectra of 14C and 3H overlap, a LSC method was
used that compensates for the inﬂuence of the other isotope. The
actual independence of 3H- and 14C-analytics was checked by mea-
suring 14C-testosterone standards in the presence and absence of
3H-testosterone and vice versa. High and low levels of matrix iso-
tope were used (3H: 242 and 12667 Bq, 14C: 587 and 1288 Bq, on
average). Linear regressions were calculated to evaluate a possible
inﬂuence. Additionally, the independence of test compound
absorption from the presence of an internal reference standard
was investigated: The absorption characteristics of 14C-MCPA and
14C-caffeine in presence and absence of 3H-testosterone as well
as 14C-testosterone in presence and absence of 3H-caffeine were
examined in the identical experimental set-up. Mean and SDs were
calculated for each group. Student’s t-test was performed with
Microsoft Ofﬁce Excel 2003. Signiﬁcance (⁄) was set at p 6 0.05,
high signiﬁcance (⁄⁄) at p 6 0.01 is indicated, too.
3. Results
3.1. Assessment of integrity tests
Evaluation of binary differentiation of human skin samples by
the standard integrity tests TEER, TEWL and TWF is based on the
results given in Tables 4–6. Shown are mean, min and max values
for the absorption of four test compounds through excised or recon-
structed human skin samples separately for valid and invalid skin
samples. The integrity or validity of the skin preparations were
judged by the standard limit values for human skin of TEER, TEWL
and TWF. TEWL and TWF lead to more skin preparations classiﬁed
as ‘invalid’ than TEER. In fact, there was almost no need for exclu-
sion with the cut-off level set 1 kX. Even the reconstructed human
skin samples providing generally a minor barrier function (Schäfer-
Korting et al., 2008) and showing apparent higher absorption values
for the test compounds, were classiﬁed as valid. In general, based on
TEWL and TWF the mean absorption values (Kp and AD) for
14C-caffeine, 14C-testosterone and 14C-MCPA were higher in invalid
skin preparations compared to the valid skin samples. However, the
min–max ranges of absorption values in valid and invalid skin prep-
arations overlapped; this is when highmax values for valid and low
min values for invalid skin samples were present. The individual
maxKp values for the single human skin preparations are visualizedTable 4
Range of absorption (minimum–maximum) of the test compounds for valid and invalid (
values. Mean values are shown in brackets. maxKp (maximal permeability constant) is giv
samples used for calculations.
Limit value classiﬁcation 2 kX
Valid Invalid
Testosterone
n 22 8
maxKp 12–283 (78) 48–80
AD 6–81 (29) 18–84
Caffeine
n 20 10
maxKp 25–994 (108) 54–16
AD 12–97 (36) 54–10
MCPA
n 11 9
maxKp 4–405 (78) 18–10
AD 9–86 (28) 13–96
MCPA-EHE
n 9 1
maxKp 0.4–2.0 (0.9) 0.4–0.
AD 1.0–9.6 (4.6) 8.9–8.in Fig. 1. In this example, classiﬁcation in valid (open symbols) and
invalid (ﬁlled symbols) skin samples is based on TEWL, cut-off
10 g m2 h1. As to be expected from the well-known higher per-
meability of reconstructed epidermis or reconstructed full-
thickness skin compared to human skin (Ackermann et al., 2010;
Schäfer-Korting et al., 2008), invalid data are predominantly
obtained when testing in the constructs (shown as triangles in
Fig. 1). If the constructs were analogously classiﬁed as principally
invalid by TWF could not be investigated in this study. Due to the
observed fragility of the tissue, including the sensitivity to washing
steps being part of this pre-test, TWFwaswaived for the constructs.
Next we tested more liberal cut-off levels. Changing the TEWL
limit from 10 to 13 g m2 h1 did not change the distribution
signiﬁcantly for 14C-caffeine and 14C-testosterone (Table 5). For
MCPA the valid results increased clearly when applying the higher
limit value and the range of valid data even included the range of
invalid in full. This effect is mainly due to the inclusion of absorp-
tion results obtained with six reconstructed human skin samples
which were obviously higher, but based on TEWL cut-off limit
13 g m2 h1 classiﬁed as valid. The very slow penetrating test
compound 14C-MCPA-2EHE showed no clear difference of absorp-
tion values in valid and invalid skin samples. This was observed
with all integrity tests (Tables 4–6). Mean, min and max values
did not differ signiﬁcantly for the two different limit values of
TWF (Table 6). However, the stricter limit value for TEER (2 kX)
led to a different distribution (Table 4). Only 2 of 90 skin samples
were classiﬁed as invalid with 1 kX as the limit, but 28 with 2 kX.
Applying the limit value 2 kX, the majority of the reconstructed
human skin samples with higher absorption results for the test
compounds were classiﬁed as invalid (23 out of 30). In contrast,
ﬁve excised human skin samples were classiﬁed as invalid despite
of absorption data in reasonable ranges. Analog to TEWL, differen-
tiation with TEER (limit: 2 kX) and TWF resulted in obvious higher
absorption means for invalid skin samples than for valid skin sam-
ples as well as in signiﬁcant overlapping of results.
In a second step linear regression analyses for the absorption
values (AD, maxKp, dependent variable y) and integrity test results
(independent variable x) were used to checkwhether integrity tests
TEER, TEWL, TWF, ISTD and BLUE are able to display minor barrier
differences between skin samples continuously. Besides human
skin, rat skin was included in these analyses. Table 7 shows mean,
min and max values of slopes and R2 derived from analysis for the
different experimental groups. One group covers experiments usingexcised and reconstructed human) skin samples differentiated by TEER at two limit
en in (⁄105 cm h1) and AD (absorbed dose) in percentages. n is the number of skin
1 kX
Valid Invalid
30 0
5 (296) 12–805 (136) –
(52) 6–84 (35) –
30 0
47 (901) 25–1647 (374) –
3 (94) 12–103 (55) –
18 2
04 (461) 4–585 (183) 715–1004 (860)
(82) 9–96 (48) 94–96 (95)
10 0
4 (0.4) 0.4–2.0 (0.9)
9 (8.9) 1.0–9.6 (5.1) –
Table 5
Range of absorption (minimum–maximum) of the test compounds for valid and invalid (excised and reconstructed human) skin samples differentiated by TEWL at two limit
values. Mean values are shown in brackets. maxKp (maximal permeability constant) is given in (⁄105 cm h1) and AD (absorbed dose) in percentages. n is the number of skin
samples used for calculations.
Limit value classiﬁcation 10 g m2 h1 13 g m2 h1
Valid Invalid Valid Invalid
Testosterone
n 19 11 19 11
maxKp 12–138 (47) 20–805 (290) 12–138 (47) 20–805 (290)
AD 6–44 (19) 32–84 (63) 6–44 (19) 32–84 (63)
Caffeine
n 19 11 20 10
maxKp 25–143 (64) 54–1647 (909) 25–143 (63) 607–1647 (995)
AD 12–68 (32) 54–103 (95) 12–68 (33) 95–103 (99)
MCPA
n 10 10 17 3
maxKp 4–365 (46) 15–1004 (455) 4–1004 (192) 442–715 (579)
AD 9–84 (21) 28–96 (84) 9–96 (45) 95–96 (95)
MCPA-EHE
n 3 7 7 3
maxKp 0.6–1.4 (0.9) 0.4–2.0 (0.9) 0.4–2.0 (0.8) 0.9–1.0 (1.0)
AD 5.1–9.6 (6.7) 1.0–8.9 (4.4) 1.0–9.6 (5.2) 2.6–8.7 (4.9)
Table 6
Range of absorption (minimum–maximum) of the test compounds for valid and invalid excised human skin samples differentiated by TWF at two limit values. Mean values are
shown in brackets. maxKp (maximal permeability constant) is given in (⁄105 cm h1) and AD (absorbed dose) in percentages. n is the number of skin samples used for
calculations.
Limit value classiﬁcation 2.5 ⁄ 103 cm h1 4.5 ⁄ 103 cm h1
Valid Invalid Valid Invalid
Testosterone
n 8 2 9 1
maxKp 12–37 (26) 20–33 (27) 12–37 (27) 20–20 (20)
AD 11–24 (17) 10–44 (27) 10–24 (16) 44–44 (44)
Caffeine
n 8 2 10 0
maxKp 30–143 (68) 77–130 (103) 30–143 (75) –
AD 30–68 (46) 51–53 (52) 30–68 (47) –
MCPA
n 4 6 8 2
maxKp 4–11 (6) 8–18 (14) 4–18 (10) 14–15 (14)
AD 9–15 (12) 12–28 (17) 9–28 (15) 15–17 (16)
MCPA-EHE
n 3 7 8 2
maxKp 0.7–1.4 (1.0) 0.4–2.0 (0.8) 0.4–2.0 (0.9) 0.4–0.9 (0.7)
AD 2.6–9.6 (5.8) 1.0–8.9 (4.8) 1.0–9.6 (4.8) 3.3–8.9 (6.1)
Fig. 1. Maximal permeability constants (maxKp) of four 14C-labeled test com-
pounds. Values are sorted by integrity class due to TEWL measurements (cut-off-
value: 10 g m2 h1). Valid human skin samples are shown as open symbols, invalid
ones as ﬁlled symbols. Excised human skin is shown in diamonds, reconstructed
human skin in triangles.
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MCPA or MCPA-2EHE) and skin preparation (excised human skin,
reconstructed human skin or excised rat skin). The correlations var-
ied over a wide range for all ﬁve methods, four test compounds and
three skin preparation types. The best correlations in average (R2:
0.484) and maximal (R2: 0.911) were achieved with the ISTD. Par-
tially good correlations were observed for TEWL: the maximal R2
of 0.790was achievedwith test compound 14C-testosterone applied
to reconstructed human skin. Even inverse correlations were occa-
sionally obtained with TEWL, TEER, TWF and BLUE but not for ISTD.
The dataset of the special investigation comprising all experiments
with 14C-MCPA applied to undamaged and gradually damaged rat
skin covers a wide range of absorption (AD 6–100%) and absorption
rates (Marzulli-Class: slow to very fast) (Marzulli and Brown, 1969).
The results of individual skin preparations correlated well with the
ISTD results (R2 of 0.859 and 0.911, respectively). The plot for AD is
shown in Fig. 2. In contrast, weak correlations exist between TEWL
and AD (R2: 0.598) and maxKp (R2: 0.451) as well as TEER and AD
(R2: 0.386) and maxKp (R2: 0.479). The quality of ﬁt was not related
Table 7
Overview of correlations between penetration results (absorbed dose, AD and maximal permeability constant, maxKp) of test compound (TC) and outcome of integrity tests.
Correlations were calculated for each homogeneous experiment – each TC (testosterone, caffeine, MCPA or MCPA-2EHE) and barrier system (excised human skin, reconstructed
human skin or rat skin) combination – alone. Shown are the maximal (max) and minimal (min) slopes and correlation coefﬁcients (R2) of all experimental groups (n). Mean values
for R2 are only calculated from experiments with correct positive or negative correlation. Regarding theory the slope is expected to be positive for ISTD, TWF, TEWL, BLUE and
negative for TEER.
TEER TEWL TWF 3H-ISTD BLUE
AD maxKp
Slope R2 Slope R2 Slope R2 Slope R2 Slope R2 Slope R2
maxKp (TC)
n 8 7 9 7 4 2 6 6 4 3
Mean 68.48 0.237 2.25 0.230 0.07 0.259 1.24 0.475 0.04 0.243
Min 359.2 0.017 26.37 0.006 0.005 0.212 0.05 0.139 0.21 0.154
Max 2.93 0.691 27.62 0.757 0.27 0.307 4.10 0.911 0.02 0.391
AD (TC)
n 8 3 9 7 4 3 6 6 4 1
Mean 0.39 0.360 1.33 0.377 0.02 0.257 0.73 0.484 0.06 0.433
Min 8.70 0.036 0.82 0.030 0.005 0.064 0.13 0.142 0.01 0.433
Max 7.64 0.658 4.59 0.790 0.05 0.628 1.13 0.859 0.26 0.433
Fig. 2. Correlation of percent potentially absorbable dose (AD) of the test
compound 14C-MCPA and AD of the internal reference standard 3H-testosterone
with rat skin. The large absorption range was achieved by chemical and mechanical
pretreatment of the rat skin samples as described in Table 2. Open diamonds
represent damaged skin samples (experiments 4–9) and ﬁlled diamonds represent
undamaged skin preparations (experiments 1 and 2: no pretreatment in black;
experiment 3: pretreatment with water without mechanical washing in gray). The
35% line represents the provisional cut-off value.
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poor correlations were obtained with excised human skin, recon-
structed human skin as well as excised rat skin.
Finally, to assess and compare the variabilities of the integrity
tests (TEER, TEWL, TWF and BLUE), the overall, inter-donor andTable 8
Variability of in vitro dermal absorption experiments and ﬁve integrity tests based on res
14C-TC ADa 14C-TC maxKpa TEER
Overall variability:c CV
(n)
– – 64%
(65)
Inter-donor variability:d CV
(D;N)
– – 45%
(11;16
Intra-donor variability:d pooled CV
(D;N)
45%
(11;20)
33%
(11;20)
43%
(11;16
a Only the pooled variation coefﬁcient (CV) was calculable for the test compound (TC
b Results from three dermatomed skin samples with excessive high values for BLUE i
c Overall variability was calculated with the mean and standard deviation (SD) for n rep
the relative SD.
d Inter-donor variability was calculated with the mean values for each single donor
method variability, was calculated with the CVs of each single donor weighted by th
dermatomed and full-thickness skin, whereby both resulted in generally comparable
calculations. The resulting number of independent values is given as N.intra-donor or method variabilities were calculated. The results
are given in Table 8. For instance, TEER resulted in CVs of 65%,
45% and 43%, respectively. Furthermore the method variability of
the in vitro dermal absorption experiments (45% and 33% regard-
ing AD and maxKp, respectively) and the ISTD (30% and 38%
regarding AD and maxKp, respectively) are given.3.2. Veriﬁcation of ISTD approach
The independency of 3H- and 14C-analytics was proven by the
quantiﬁcation of 14C-testosterone standards in presence of 3H-tes-
tosterone at two dose levels in comparison to 14C-testosterone
standards without 3H in the matrix (Fig. 3). The R2 was 0.9991
and the slope 1.0077. No general inﬂuencing effects were apparent.
This holds also true with 3H-testosterone levels measured without
the addition of the 14C-labelled steroid and following the addition
of this label at a high and low amount. Then the R2 was 0.9998 and
the slope 1.0008 (data not shown). In the very low Bq range
(<200 Bq) of 3H-testosterone the presence of 14C increased the var-
iability of 3H-testosterone data.
To assess the co-absorption of test compound and internal
reference standard, Table 9 lists absorption characteristics for three
14C-labeled test compounds in absence and presence of a
3H-labeled ISTD. Except for a signiﬁcantly different lag time for
14C-testosterone with and without 3H-caffeine all endpoints of der-
mal absorption were close and the ISTD did not inﬂuence the
absorption of the test compound.ults with excised human skin from different donors.
TEWL TWF 3H-ISTD ADa 3H-ISTD maxKpa BLUEb
55%
(65)
61%
(40)
– – 56%
(37)
)
48%
(11;16)
32%
(5;10)
– – 44%
(5;10)
)
57%
(11;16)
53%
(5;10)
30%
(9;18)
38%
(9;18)
43%
(5;10)
) and ISTD due to the various TCs and ISTDs used.
ndicating damaged skin samples were excluded from the calculations.
licates of humen skin samples and is given as CV in percentages and corresponds to
(D: number of donors); intra-donor variability or pooled CV, corresponding to the
e number of replicates; for both means and CVs were calculated separately for
values (data not shown) – and separately for each ISTD or TC for the respective
Fig. 3. Correlation of radioactive concentration of 14C-testosterone in absence and presence of 3H-testosterone as determined by LSC. 14C-concentrations are shown in ﬁlled
squares. Added high and low dose 3H-concentrations are shown in open triangles. Insertion shows magniﬁed low concentration rage (<200 Bq g1).
Table 9
Absorption results of 3 different test compounds (TC) in absence () and presence (+) of a tritium labeled internal reference standard (3H-ISTD) through
excised human skin. Statistics: students t-test.
14C-TC 3H-ISTD Skin (%) Receptor (%) maxKp (⁄105 cm h1) Lag time (h)
Caffeine  0.5 ± 0.2 19.6 ± 6.0 62.5 ± 13.8 3.0 ± 1.1
+ Testosterone 0.6 ± 0.3 16.5 ± 3.7 40.9 ± 16.6 4.0 ± 0.9
Testosterone  1.7 ± 1.3 24.5 ± 10.6 69.3 ± 25.1 4.4 ± 1.5
+ Caffeine 0.4 ± 0.2 17.3 ± 14.8 61.8 ± 47.0 2.4 ± 0.4*
MCPA  2.5 ± 2.4 9.2 ± 3.6 15.6 ± 14.6 1.1 ± 0.9
+ Testosterone 4.3 ± 0.9 12.6 ± 1.2 21.4 ± 10.4 0.7 ± 0.4
* p < 0.05.
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TEER, TEWL and TWF are widely used skin integrity tests, each
with a large historical dataset (Bronaugh et al., 1986; Davies et al.,
2004; Diembeck et al., 1999; Elkeeb et al., 2010; Meidan and Roper,
2008). Nevertheless there are still discussions about the experi-
mental performances, limit values and ﬁelds of application
(Chilcott et al., 2002; Meidan and Roper, 2008; Netzlaff et al.,
2006). Impairment of the skin barrier identiﬁed by these methods
is expected to allow excessive penetration and permeation of the
test compound and therefore yield invalid results. Usually cut-off
values are used to distinguish impaired from intact skin prepara-
tions with no intermediate stages: a skin sample is either valid
or invalid. This is helpful in case of a pre-test that rejects inappro-
priate samples for absorption testing. Compromising the barrier of
a skin preparation is, however, a continuous phenomenon ranging
from intact to increasingly more permeable barriers and can occur
before the study started, during the test compound application
(sometimes even caused by the compound, more often by the vehi-
cle) or after the application (e.g. during washing of the skin). To
obtain a complete picture of the barrier integrity, an advanced
integrity test would detect the continuum of barrier impairments
and barrier defects may correlate with the absorption of the test
compound through the very skin preparation.4.1. Evaluation of the three standard methods TEER, TEWL and TWF
To address the binary differentiation of human skin samples
into valid and invalid, we compared the absorption results (AD
and maxKp) of four test compounds (caffeine, testosterone, MCPA
and MCPA-EHE) applied to excised or reconstructed human skin.
The results were grouped by integrity test classiﬁcation (valid/
invalid) according to the three standard tests TEER, TEWL andTWF operated at two cut-off levels. Mean values for valid human
skin samples sorted by TEWL or TWF were generally higher than
means for invalid skin samples. The valid absorption results for
14C-caffeine and 14C-testosterone (Tables 5 and 6) were in good
accordance with absorption studies for (14C-) caffeine 56 ± 36 ⁄
105 cm h1 (maxKp) and 30 ± 14% (AD) and (14C-) testosterone
41 ± 48 ⁄ 105 cm h1 (maxKp) and 20 ± 15% (AD) through human
skin (van de Sandt et al., 2004). 29 out of 30 reconstructed human
skin samples were identiﬁed as invalid by TEWL measurements,
which was in accordance to obviously higher absorption values
in comparison to excised human skin samples. Generally higher
absorption through reconstructed human epidermis and recon-
structed human full-thickness skin in comparison to native human
skin and pig skin was reported previously (Ackermann et al., 2010;
Schäfer-Korting et al., 2008). The outlined observations conﬁrm a
meaningful differentiation of skin samples using integrity tests
TEWL or TWF. However, some single skin samples with average
permeability were identiﬁed as invalid and a few as valid which
presented obvious too high maxKp and AD values. Deterioration
of the skin during the experiment just due to time or caused by
detergent and manipulation during washing procedure can be
reasons for false valid classiﬁcations (Buist et al., 2005). Such
effects can only be considered and evaluated by concurrent or
post-experimental integrity tests. Interestingly the EFSA ‘‘Guidance
on Dermal Absorption’’ recommends to avoid post experimental
integrity tests (EFSA Panel on Plant Protection Products and their
Residues, 2012). Prevention of inappropriate skin rejection due to
compound related barrier damages could be reasons for this rec-
ommendation. However, diminished barrier function of single skin
preparations after an experiment may provide valuable informa-
tion, for instance, hints for an inappropriate over-prediction of der-
mal absorption. In contrast, if all skin preparations are affected,
showing impaired barrier functionality, a destructive effect of the
applied formulation is implied.
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are set to strict. To address this we also applied besides our stan-
dard TEWL limit of 10 g m2 h1 and the well-established TWF
limit value of 2.5 ⁄ 103 cm h1 (Bronaugh et al., 1986) for human
skin, higher values of 13 g m2 h1 and 4.5 ⁄ 103 cm h1 (Meidan
and Roper, 2008). For TEWL it makes no signiﬁcant difference: with
both restrictions the valid mean for 14C-caffeine and 14C-testoster-
one was in accordance with reference values (van de Sandt et al.,
2004); but inclusion of several high maxKp values and ADs for
14C-MCPA – due to the less strict limit value – led to obviously
higher mean values for skin that was classiﬁed as valid. To avoid
inclusion of such apparent over-predicted values for mean calcula-
tions, the stricter limit value for TEWL or a combination of different
integrity tests is advisable. Both limit values for TWF led to similar
valid and invalid values. With both limits many skin samples were
considered as invalid in contrast to absorption results in reason-
able ranges and TEWL classiﬁcations. To avoid unnecessary rejec-
tion of skin samples by this sensitive method, the higher limit
value is recommendable.
A large number of the reconstructed human skin samples show-
ing increased absorption results were not identiﬁed as invalid with
the standard TEER limit of 1 kX, but almost all with the stricter
limit of 2 kX. It seems that the standard limit value of 1 kX, orig-
inally derived from experiments with native versus punched
human skin samples, is unable to detect minor damages. Further-
more the 2 kX limit provides more reasonable mean values for
valid samples as 14C-caffeine and 14C-testosterone absorption in
accordance with previous data (van de Sandt et al., 2004). Rather
homogeneous MCPA-2EHE absorption appears to indicate that no
impaired skin sample was apparent (Fig. 1). However, some skin
samples identiﬁed as invalid by TEWL, TWF and TEER (2 kX)
(Tables 4–6) once more highlights the probability to discard
integer skin samples and the usefulness of concurrent or post-
experimental integrity tests. Furthermore, the applicability of
TEWL, TWF and TEER as integrity tests in dermal absorption stud-
ies for highly lipophilic compounds could be questioned in general.
Focusing on the permeation/loss of water or permeation of small
electrolytes through the skin, these tests are suitable to identify
changes in the polar pathway of the skin. Changes in the lipid
pathway, which is relevant for highly lipophilic compounds like
MCPA-2EHE, can be overlooked; meaning that these tests are not
representative for the penetration of highly lipophilic compounds.
The contribution of polar- and lipid-intercellular, intracellular and
appendageal pathways through skin depend on the physico-
chemical properties of the test compound (Flynn et al., 1974;
Roberts and Cross, 2002).
Rougier et al. observed good correlations between TEWL and
absorption of benzoic acid in vivo (Rougier et al., 1988). However,
the comparability of water ﬂow through skin tissue in vivo and
in vitro is limited. Previous work about TEWL application in vitro
indicates that only severe damages can be detected (Netzlaff
et al., 2006). The same conclusion is drawn for the current work
where no, poor or even inverse correlations were observed
between TEER, TEWL or TWF and test compound absorption
(Table 7). Yet, the stated general applicability for in vitro testing
failed to reﬂect 14C-mannitol (Lawrence, 1997) and 35sulfur mus-
tard absorption in vitro (Chilcott et al., 2002). A lack of correlation
to highly lipophilic test compounds was reported, too (Levin and
Maibach, 2005).
Taken together all three standard tests are able to sort out a
substantial part of impaired human skin samples in general. Limit
values of 2 kX, 10 g m2 h1 and 4.5 ⁄ 103 cm h1 for TEER, TEWL
and TWF, respectively, seem appropriate to judge between
unwanted use of impaired skin and unnecessary rejection of skin
samples. However, destruction of barrier function during the
experiment does not become obvious by these tests and – shownby falsely classiﬁed skin – only a rough differentiation is possible.
Furthermore, none of the named integrity tests seems universally
applicable. Deﬁned ‘applicability domains’ for each integrity test
which limits their use to test compounds in speciﬁc physico-
chemical spaces or to speciﬁc experimental conditions (in vitro
and/or in vivo, human and/or rat skin, excised and/or recon-
structed skin etc.) can help to choose the most indicative test for
the relevant case. Moreover, future use of reconstructed human
skin for testing of dermal absorption asks for the adjustment of
the generated data to human skin based on a prediction model
(Schäfer-Korting et al., 2008) which still needs to be set up. For this
purpose, the cut-off values need to be adapted as well.
4.2. Evaluation of ISTD and BLUE in relation to standard methods
Because of the limitations of the standard integrity tests (TEER,
TEWL and TWF), two other integrity parameters (ISTD, BLUE) were
checked for their ability to correlate with absorption results and
explain continuous differences of the skin barrier function.
Extreme outliers were clearly identiﬁed with BLUE, but correla-
tions to test compound absorption were poor and partly even
inverse. Although a general applicability of BLUE cannot be ruled
out, lack of advantage over established tests makes further
investigations redundant. The opposite was true for ISTD. These
results were positively and highly correlated with test compound
results. The correlation over a wide absorption range of 14C-MCPA
(6–100%) to 3H-testosterone as internal reference standard was
0.859 (n = 45). Comparison of results for normal and intentionally
damaged rat skin samples suggests under these experimental con-
ditions (rat skin, receptor ﬂuid water) a provisional cut-off value of
35% AD 3H-testosterone (Fig. 2). The good correlation and the
possibility to monitor the skin over the whole experimental time
make the ISTD a promising tool. Besides other aspects it could help
to distinguish compound-speciﬁc wash-in effects from barrier-
disruption related effects.
In contrast to the recommendation of the OECD-Guideline we
decided against 3H-sucrose as ISTD because of poor information
about applicability and the set limit value of 5% absorption
(Walters et al., 1997). Moreover, the very high hydrophilic com-
pound sucrose is not representative for routinely tested lipophilic
test compounds. In accordance with the above-mentioned ‘appli-
cability domain’ for integrity tests, the ISTD should be selected
on the basis of the physico-chemical properties of the test com-
pound, to indicate representatively the barrier function in relation
to the respective pathway through the skin. Another suggested ref-
erence compound for ISTD is phenol red. Yet a 100 times higher
concentration of phenol red is needed to achieve the same analyt-
ical sensitivity as the 3H-labeled reference compounds and high
concentrations increase the risk to inﬂuence the test results
(Dugard and Scott, 1986).
To get a ﬁrst impression of the performance of different ISTDs,
3H-caffeine and 3H-mannitol were tested in parallel to 3H-testos-
terone in human skin experiments. The combination 3H-testoster-
one and 14C-MCPA resulted in moderate and weak correlations (R2
0.52 and 0.16 for AD and maxKp comparison, respectively). This is
probably due to the divergent physico-chemical properties (logP
3.32 and 0.71 (at pH 7) and MW 288.4 and 200.6 g mol1 for
testosterone and MCPA, respectively), but also due to the narrow
absorption range which was covered. In fact, once the absorption
range was expanded, as done in the special investigation with
damaged and undamaged rat skin, the correlation was improved
(R2 0.859 and 0.911 against AD and maxKp, respectively). Weak
correlations were obtained with 3H-mannitol as ISTD with
14C-testosterone (R2 0.34 and 0.14 for AD and maxKp comparison,
respectively) and 14C-caffeine (R2 0.20 and 0.40 for AD and maxKp
comparison, respectively). Also in this case, the distance of the logP
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test compounds was probably too large. For the combination
14C-testosterone and 3H-caffeine, having closer logP values, the
best correlations with human skin were obtained (R2 0.62 and
0.81 for AD and maxKp comparison, respectively). However, the
reverse case (3H-testosterone and 14C-caffeine) resulted in weaker
correlations (0.59 for maxKp comparison) and even no correlation
(R2 0.04 for AD comparison) – probably due to a lower number of
replicates (n = 5) and one obvious outlier. Summing up, an ISTD
with close physico-chemical properties to the test compound is
preferable; however, the results imply that also ISTDs with a cer-
tain distance to the test compound are applicable.
Finally, the suitability of the current ISTD approach was proven
by the independence of 14C-analytics by LSC in the presence of 3H
(Fig. 3) and at maximum a negligible inﬂuence of 14C-presence on
3H-analytics (Table 9) as well as the independence of absorption
results from the presence of an internal reference standard in neg-
ligible concentrations.
4.3. Variability of integrity tests and donor inﬂuence
To assess the intrinsic variability of the integrity tests and the
effect of the human donor on the results, the overall, the inter-
donor and the intra-donor variabilities were calculated for TEER,
TEWL, TWF and BLUE (Table 8). For TEER, CVs for the overall, the
inter-donor and the intra-donor variability were 64%, 45% and
43%, respectively. This implies that the variability of the method,
given as the intra-donor variability, is close to the inter-donor var-
iability and therewith covering the donor effect. The same is true
for the other integrity tests (TEWL, TWF and BLUE), for which the
donor effect was also close to the method variability. Therewith,
a clear separation of human donors based on the integrity test
results is hardly possible. Additionally, means and overall variabil-
ity of the different integrity tests were calculated for full-thickness
and dermatomed human skin separately (data not shown). In gen-
eral, the values were close within each integrity test. For instance,
TWF results were 302 ± 188 ⁄ 105 cm h1 (n = 20, CV = 62%) and
248 ± 146 ⁄ 105 cm h1 (n = 20, CV = 59%) for dermatomed and
full-thickness skin from the same human donors, respectively. This
is in line with the previously reported comparability of absorption
results through both skin preparation types (Guth, 2013). Further-
more, the donor effect was consistent over all methods with values
ranging from 32% to 48%. These values were also in line with the
general donor effect observed for dermal absorption experiments
in vitro being 43% (Southwell et al., 1984). The overall method
variabilities determined in this study for four different test com-
pounds are with CVs of 33% and 45% for maxKp and AD, respec-
tively, in line with the reported variability ranging from 2% to
111% (Southwell et al., 1984; van de Sandt et al., 2004). The
method variabilities obtained for all ﬁve integrity tests, including
ISTD, are in the same range (30–57%).
4.4. Solitary versus continuous integrity tests
The ISTD is advantageous over the ‘solitary’ integrity tests con-
ducted in advance or after an absorption experiment, since outliers
or abnormalities observed for the kinetics of the test compound can
be interpreted in parallel with the kinetics of the ISTD. For instance,
an abrupt increase of absorption of the test compound after the
washing procedure is classiﬁed as a wash-in effect due to mechan-
ical disruption of the barrier if the ISTD shows a parallel effect, or it
is classiﬁed as a substance-speciﬁc wash-in effect if the absorption
of the ISTD is not affected. The latter case – washing increases the
test compound absorption – can be relevant for regulatory pur-
poses. In addition, formulation-related barrier impairment could
be identiﬁed. If all skin samples are affected, resulting in higherabsorption rates for ISTD in comparison to historical control data,
the formulation inﬂuences the barrier function (irritation, distur-
bance or disruption). In contrast, if only few, e.g. two out of eight,
skin samples are affected, it is a sign for per se impaired skin sam-
ples whose results need to be rejected. Furthermore, systematic
errors could be evaluated. For instance, if higher skin temperatures
or higher receptor ﬂow rates are logged during an experiment, ISTD
results in the historical range will argue against an effect of these
variations on the test compound absorption or in other words will
argue for a valid experiment. And ﬁnally a continuous test avoids
any kind of pretreatment and elongation of the experiment which
could alter the skin properties as outlined above (Buist et al.,
2005). However, besides all these advantages, a continuous test is
unsatisfactory as a stand-alone method. No preselection of skin
samples is made, why impaired skin samples might be used. To
avoid an insufﬁcient number of valid skin samples for the entire
study, we recommend a combined use of the binary standard test
TEWL in advance of an experiment – which is able to identify the
majority of defect skin samples without pretreatment of the skin
samples – and the outlined continuous ISTD approach – to evaluate
effects observed during the absorption experiment. Since good cor-
relations were observed for all skin preparation types (excised
human, reconstructed human and excised rat skin), the ISTD
approach is probably transferable to diseased skin or reconstructed
diseased skin (Kuechler et al., 2011; Oji et al., 2010) as well.
However, an obstacle for the routine application of the ISTD
approach is the need of a broad, publicly available, historical data-
set. In theory, this dataset should be a matrix of various ISTDs with
different physico-chemical properties applied under several exper-
imental conditions. Compounds with various logP values and MWs
should be included, since these properties mainly determine their
dermal absorption (Riviere, 2011). This would allow adjustment of
the reference compound to the physico-chemical properties of the
test compound in order to address the same pathway through the
skin. However, to keep it practicable for routine application it is
recommended to establish at least representatives for high, med-
ium and low logP ranges. This would be in parallel to the suggested
reference compounds stated in the guideline (caffeine, benzoic acid
and testosterone) (OECD, 2004b) and cover different pathways
through the skin. The ISTD with the logP value closest to the logP
value of the test compound should be chosen for the experiment.
That a certain distance is generally acceptable was shown in the
current work. Since different conditions (like donor or receptor
ﬂuid) can inﬂuence the ISTD results (Kielhorn et al., 2006;
Schäfer and Redelmeier, 1996a) there is also a need to generate
data under the relevant scenarios. For the investigation of pesti-
cides a breakdown to three scenarios is conceivable: aqueous
donor and aqueous receptor, organic donor and organic/aqueous
receptor, organic donor and aqueous receptor. To gain experience
concerning the effect of formulation on the ISTD, additional exper-
iments using ISTD in parallel to standard routine experiments
without ISTD are feasible. If no data of intentionally damaged skin
is available for setting a cut-off limit (as done in the current work,
Fig. 2), routine data could be used to depict a frequency histogram
and use the 95th percentile threshold as previously done for TWF
(Fasano et al., 2002; Meidan and Roper, 2008).5. Conclusion
In conclusion the standard integrity tests TEER, TEWL and TWF
are useful to distinguish between impaired and intact human skin
samples prior to a dermal absorption experiment, if limit values of
10 g m2 h1, 4.5 ⁄ 103 cm h1 and 2 kX, respectively, are applied.
The application of one of these tests is recommended for routine
experiments. Furthermore, adding an internal reference standard
K. Guth et al. / Toxicology in Vitro 29 (2015) 113–123 123to the test compound allows a continuous assessment of the bar-
rier functionality over the entire experimental period. Combining
both, an effective and non-invasive pre-test like TEWL and the con-
cept of ISTD could improve the quality of dermal absorption exper-
iments in the future. However, the routine application of ISTD is
hampered by the need of a historical dataset which is required to
deﬁne thresholds of integrity and develop a general protocol.
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